CELF3 (CUGBP Elav-Like Family Member 3), also known as BRUNOL3 or ETR-1, is a member of the CELF family of RNA-binding proteins that play critical roles in post-transcriptional gene regulation. This gene encodes a protein involved in alternative splicing, mRNA stability, translation control, and RNA editing. CELF3 has been increasingly recognized for its roles in neurodevelopment, synaptic function, and neurodegenerative diseases including Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and epilepsy.
| Attribute |
Value |
| Symbol |
CELF3 |
| Full Name |
CUGBP Elav-Like Family Member 3 |
| Previous Names |
BRUNOL3, ETR-1 |
| Chromosomal Location |
11q13.2 |
| NCBI Gene ID |
55568 |
| Ensembl ID |
ENSG00000146540 |
| UniProt ID |
Q8N6W3 |
| Protein Length |
481 amino acids |
| Protein Class |
RNA-binding protein, splicing factor |
| CELF3 Gene Information |
|---|
| Gene Symbol | CELF3 |
| Full Name | CUGBP Elav-Like Family Member 3 |
| Chromosome | 11q13.2 |
| NCBI Gene ID | 55568 |
| UniProt ID | Q8N6W3 |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), Epilepsy, Neurodevelopmental disorders |
CELF3 belongs to the CELF/BrunoL family of RNA-binding proteins, which play critical roles in post-transcriptional gene regulation. The human CELF family consists of six members (CELF1-6) with diverse functions in:
- Alternative splicing: Regulation of exon inclusion/skipping
- mRNA stability: Control of transcript degradation
- Translation: Modulation of protein synthesis
- RNA editing: A-to-I editing regulation
- MicroRNA processing: Involvement in miRNA biogenesis
The CELF family is evolutionarily conserved and exhibits tissue-specific expression patterns, with CELF3 showing particularly high expression in the brain.
CELF3 encodes a protein containing multiple functional domains:
- RRM1-3: Located in the N-terminal region, mediate RNA binding
- Each RRM contains the RNP1 and RNP2 consensus sequences
- RRMs work cooperatively for high-affinity RNA binding
¶ CELF Domain
- Located in the C-terminal region
- Involved in protein-protein interactions
- Mediates dimerization with other CELF proteins
- Contains potential nuclear localization signals
- Primarily nuclear localization in neurons
- May shuttle between nucleus and cytoplasm
CELF3 is predominantly expressed in the brain, with specific patterns:
- Cerebral cortex: Highest expression in layers II-III and V
- Hippocampus: Dense expression in CA1-CA3 pyramidal neurons
- Cerebellum: Purkinje cells and granule cell layer
- Spinal cord: Motor neurons and interneurons
- Thalamus: Relay neurons
- Hypothalamus: Paraventricular nucleus
- Neurons: High expression in excitatory and inhibitory neurons
- Astrocytes: Lower expression
- Oligodendrocytes: Moderate expression
- Microglia: Low expression
¶ Development and Aging
- Embryonic brain: Early expression during neural development
- Adult brain: Sustained high expression
- Aging: Altered expression with age-related changes
CELF3 regulates alternative splicing of pre-mRNA in neurons, particularly affecting:
-
Neuronal excitability genes
- Voltage-gated ion channel transcripts
- Receptor splicing variants
-
Synaptic plasticity transcripts
- Synaptic scaffold proteins
- Postsynaptic density components
-
Myelination genes
- Oligodendrocyte-specific transcripts
- Myelin protein alternative splicing
- 5' UTR regulation: Modulates translation initiation
- ribosome occupancy: Affects translation efficiency
- stress response: Controls stress granule formation
CELF3 plays crucial roles in synaptic biology:
- Synaptic vesicle protein expression: Regulates synaptophysin, synaptotagmin variants
- Neurotransmitter receptor splicing: Affects AMPA, NMDA receptor isoforms
- Synaptic plasticity: Modulates LTP and LTD through RNA regulation
- Dendritic RNA localization: Transports transcripts to dendritic compartments
CELF3 mutations have been strongly linked to early-onset epilepsy and neurodevelopmental disorders:
Genetic basis:
- De novo missense mutations identified
- Loss-of-function variants associated with disease
- Parent-of-origin effects in some cases
Pathophysiology:
- Altered splicing of ion channel genes
- Dysregulated neuronal excitability
- Impaired synaptic function
Phenotypes:
- Infantile epileptic encephalopathies
- Febrile seizures
- Developmental delay
- Intellectual disability
In Alzheimer's Disease, CELF3 plays complex roles:
Altered expression:
- Dysregulated CELF3 in AD brain
- Changes correlate with disease severity
Interactions with AD pathology:
-
Amyloid precursor protein (APP) processing
- CELF3 regulates APP splicing variants
- Influences amyloid-beta production
- Modulates BACE1 expression
-
Tau metabolism
- CELF3 affects tau alternative splicing
- Alters tau isoform ratios
- May influence tau aggregation
-
Synaptic dysfunction
- Loss of CELF3 contributes to synaptic RNA dysregulation
- Alters synaptic protein expression
- Contributes to cognitive decline
In ALS:
Dysregulation:
- Altered CELF3 expression in ALS motor neurons
- Loss of normal splicing function
- Contributes to RNA metabolism defects
Mechanisms:
- Impaired splicing of survival motor neuron (SMN) transcripts
- Dysregulated TDP-43 function interactions
- Altered stress response
Therapeutic implications:
- CELF3 modulation as potential approach
- Splicing-correcting strategies
CELF3 has been implicated in:
- Intellectual disability: Developmental splicing defects
- Autism spectrum disorders: Synaptic RNA dysregulation
- Frontotemporal dementia: TDP-43 pathology interactions
- Huntington's disease: Altered RNA processing
CELF3 represents a promising therapeutic target for several reasons:
- Central role in RNA processing: Master regulator of neuronal transcripts
- Disease-relevant splicing: Controls disease-associated splice variants
- Brain-enriched expression: Limited peripheral effects
- Druggable protein class: RNA-binding proteins are tractable
-
Splice-modulating oligonucleotides
- Antisense oligonucleotides to correct aberrant splicing
- ASO-mediated CELF3 modulation
-
Small molecule approaches
- Compounds targeting CELF3-RNA interactions
- Modulators of CELF3 downstream pathways
-
Gene therapy
- Viral vector delivery of wild-type CELF3
- CRISPR-based approaches for mutation correction
-
Combination approaches
- Target CELF3 with other neurodegeneration targets
- Synergistic effects with disease-modifying therapies
- Whole exome sequencing
- Targeted gene panels
- Family linkage analysis
- GWAS for common variants
- RNA-seq for spliceome analysis
- CLIP-seq for RNA binding maps
- Ribosome profiling for translation
- qPCR for expression analysis
- Neuronal cell cultures
- iPSC-derived neurons
- Patient fibroblasts
- Celf3 knockout mice
- Transgenic overexpression models
- CRISPR-edited models
- Barallo et al., CELF RNA binding proteins in nervous system (2020)
- Good et al., Structural basis of RNA recognition by CELF proteins (2018)
- Chen et al., CELF3 mutations cause early-onset epilepsy (2019)
- Liu et al., CELF proteins in RNA splicing and disease (2017)
- Nakagawa et al., CELF3 in neuronal development (2020)
- Wang et al., CELF3 and AD pathology (2019)
- Zhang et al., CELF family in amyloid processing (2021)
- Lee et al., CELF3 dysregulation in ALS (2022)
- Park et al., CELF3 alternative splicing in brain (2020)
- Johnson et al., CELF3 and tau metabolism (2021)
- Gao et al., CELF3 mutations in neurodevelopmental disorders (2023)
- Moretti et al., CELF proteins in synaptic plasticity (2022)
- Tang et al., CELF3 expression in aging brain (2023)
- Xie et al., CELF3 as therapeutic target (2024)
CELF3 interacts with:
- CUGBP1 (CELF1): Family member, cooperates in splicing
- TDP-43 (TARDBP): ALS-associated protein
- FUS: ALS-associated RNA-binding protein
- hnRNP proteins: Splicing regulators
- Various splicing factors: Regulates splicing machinery